Oncology & Cancer

Enhanced tumor modeling using Laponite bioinks for 3D bioprinting

Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed a nanoengineered bioink with improved bonding and cross-linking capabilities for 3D bioprinting of tumor models. A key component of this ...

Oncology & Cancer

The challenges of cancer vaccines

The first therapeutic cancer vaccine has now been approved by the FDA, and a diverse range of therapeutic cancer vaccines directed against a spectrum of tumor-associated antigens are currently being evaluated in clinical ...

Oncology & Cancer

Mechanism of an effective MEK inhibitor identified

Understanding the effects of certain targeted therapies on antitumor immunity is necessary to design combined interventions for more effective cancer treatment. In the past, data have shown that trametinib, an FDA-approved ...

Oncology & Cancer

Investigating mechanisms of aggressive glioblastoma tumor growth

Northwestern Medicine investigators have identified a metabolism-related gene that may play a role in recruiting immune cells to support the growth of aggressive brain tumors, according to a study recently published in Nature ...

page 33 from 40